SPG STIMULATION FOR ENHANCING NEUROGENESIS AND BRAIN METABOLISM

• US 20090210026A1
• Filed: 08/25/2008
• Published: 08/20/2009
• Est. Priority Date: 08/17/2006
• Status: Abandoned Application

• Current Assignee: BrainsGate Ltd.
• Original Assignee: BrainsGate Ltd.
• Inventors: Ariav, Gal, Solberg, Yoram, Altman, Hernan, Dayan, Avinoam
• Application Number:
  US12/197,614
• Publication Number:
  US 20090210026A1
• Time in Patent Office: Days
• US Class Current: 607/45
• CPC Class Codes: A61N 1/36017 with leads or electrodes penetrating the skin
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
• CPC Class Codes: A61N 1/3787 from an external energy source

Abstract

A method is provided, including identifying an electrical stimulation protocol as being suitable for augmenting genesis of one or more cell populations in at least one brain region of the subject. The cell genesis is augmented by applying the identified stimulation protocol to an SPG, a greater palatine nerve, a branch of the greater palatine nerve, a lesser palatine nerve, a sphenopalatine nerve, a communicating branch between a maxillary nerve and an SPG, an otic ganglion, an afferent fiber going into the otic ganglion, an efferent fiber going out of the otic ganglion, an infraorbital nerve, a vidian nerve, a greater superficial petrosal nerve, a lesser deep petrosal nerve, a maxillary nerve, a branch of the maxillary nerve, a nasopalatine nerve, a peripheral site that provides direct or indirect afferent innervation to the SPG, or a peripheral site that is directly or indirectly efferently innervated by the SPG.

Claims

1. A method comprising:

identifying an electrical stimulation protocol as being suitable for augmenting genesis of one or more cell populations in at least one brain region of the subject; and

augmenting the cell genesis by applying the identified stimulation protocol to a site of the subject selected from the group consisting of;

a sphenopalatine ganglion (SPG), a greater palatine nerve, a branch of the greater palatine nerve, a lesser palatine nerve, a sphenopalatine nerve, a communicating branch between a maxillary nerve and an SPG, an otic ganglion, an afferent fiber going into the otic ganglion, an efferent fiber going out of the otic ganglion, an infraorbital nerve, a vidian nerve, a greater superficial petrosal nerve, a lesser deep petrosal nerve, a maxillary nerve, a branch of the maxillary nerve, a nasopalatine nerve, a peripheral site that provides direct or indirect afferent innervation to the SPG, and a peripheral site that is directly or indirectly efferently innervated by the SPG.

2. The method according to claim 1, wherein the site is selected from the group consisting of:

the SPG, the greater palatine nerve, the lesser palatine nerve, the sphenopalatine nerve, the communicating branch between the maxillary nerve and the SPG, the otic ganglion, the afferent fiber going into the otic ganglion, the efferent fiber going out of the otic ganglion, the infraorbital nerve, the vidian nerve, the greater superficial petrosal nerve, and the lesser deep petrosal nerve.

3. The method according to claim 1, wherein identifying the stimulation protocol comprises identifying the stimulation protocol as being suitable for augmenting neurogenesis in the at least one brain region.

4. The method according to claim 1, wherein identifying the stimulation protocol comprises identifying the stimulation protocol as being suitable for augmenting angiogenesis in the at least one brain region.

5. The method according to claim 1, wherein identifying the stimulation protocol comprises identifying the stimulation protocol as being suitable for augmenting glia-genesis in the at least one brain region.

6. The method according to claim 1, and comprising identifying that the subject suffers from an adverse cerebral condition, wherein augmenting the cell genesis comprises augmenting the cell genesis responsively to identifying that the subject suffers from the adverse cerebral condition.

7. The method according to claim 6, wherein the cerebral condition causes a brain area of the subject to be diseased, and wherein the at least one brain region is selected from the group consisting of:

a vicinity of the diseased brain area, and a brain area other than the vicinity of the diseased brain area.

8. The method according to claim 6, wherein identifying that the subject suffers from the adverse cerebral condition comprises identifying that the subject suffers from a cerebrovascular infarction.

9. The method according to claim 8, wherein augmenting the cell genesis comprising commencing applying the stimulation at least 18 hours after an occurrence of the infarction.

10. The method according to claim 1, and comprising identifying that the subject may benefit from the augmented cell genesis, wherein augmenting the cell genesis comprises augmenting the cell genesis responsively to identifying that the subject may benefit from the augmented cell genesis.

11. A method for treating a subject, comprising:

identifying an electrical stimulation protocol as being suitable for improving a metabolic state of a brain area of a subject; and

improving the metabolic state by applying the stimulation protocol to a site of the subject selected from the group consisting of;

a sphenopalatine ganglion (SPG), a greater palatine nerve, a branch of the greater palatine nerve, a lesser palatine nerve, a sphenopalatine nerve, a communicating branch between a maxillary nerve and an SPG, an otic ganglion, an afferent fiber going into the otic ganglion, an efferent fiber going out of the otic ganglion, an infraorbital nerve, a vidian nerve, a greater superficial petrosal nerve, a lesser deep petrosal nerve, a maxillary nerve, a branch of the maxillary nerve, a nasopalatine nerve, a peripheral site that provides direct or indirect afferent innervation to the SPG, and a peripheral site that is directly or indirectly efferently innervated by the SPG.

12. The method according to claim 11, wherein the site is selected from the group consisting of:

the SPG, the greater palatine nerve, the lesser palatine nerve, the sphenopalatine nerve, the communicating branch between the maxillary nerve and the SPG, the otic ganglion, the afferent fiber going into the otic ganglion, the efferent fiber going out of the otic ganglion, the infraorbital nerve, the vidian nerve, the greater superficial petrosal nerve, and the lesser deep petrosal nerve.

13. The method according to claim 11, wherein identifying the stimulation protocol comprises identifying the stimulation protocol as suitable for reducing a lactate concentration in the brain area.

14. The method according to claim 11, and comprising identifying that the subject suffers from an adverse cerebral condition, wherein improving the metabolic state comprises improving the metabolic state responsively to identifying that the subject suffers from the adverse cerebral condition.

15. The method according to claim 14, wherein identifying that the subject suffers from the adverse cerebral condition comprises identifying that the subject suffers from a cerebrovascular infarction.

16. The method according to claim 14, wherein improving the metabolic state comprises commencing applying the stimulation at least 18 hours after an occurrence of the infarction.

17. The method according to claim 14, wherein the brain area is an ischemic core of the infarction.

18. The method according to claim 17, wherein identifying the stimulation protocol comprises identifying the stimulation protocol as suitable for reviving at least a portion of the ischemic core.

19. The method according to claim 14, wherein the brain area is an ischemic penumbra of the infarction.

20. The method according to claim 19, wherein identifying the stimulation protocol comprises identifying the stimulation protocol as suitable for reviving at least a portion of the ischemic penumbra.

21. The method according to claim 11, and comprising identifying that the subject may benefit from the improved metabolic state, wherein improving the metabolic state comprises improving the metabolic state responsively to identifying that the subject may benefit from the improved metabolic state.